ATS 2019 Virtual Final Program

208 Clinical and Genetic Features of Visual and Quantitative CT Subtypes in the COPDGene Study/ J. Park, B.D. Hobbs, P. Sakornsakolpat, M.H. Cho, D.A. Lynch, E.K. Silverman, Boston, MA, p.A1119 209 Relationship Between Smoking History and CT Measures of Occult Lung Disease in Smokers with Preserved Spirometry in SPIROMICS/ A. Oh, E.A. Hoffman, D. Couper, M.K. Han, R.G. Barr, R.P. Bowler, C.B. Cooper, A.P. Comellas, G.J. Criner, M.T. Dransfield, N.N. Hansel, J.A. Krishnan, R. Paine, S.P. Peters, P. Woodruff, S. Christenson, San Francisco, CA, p.A1120 210 Gallium-68 V/Q PET-CT Versus Conventional CT Densitometry for Quantification of Emphysema Severity?/ D. Steinfort, A. Bonney, P.-Y. Le Roux, S. Siva, J. Callaghan, L. Irving, M. Hofman, Parkville, Australia, p.A1121 211 Regional Gas Exchange Function Before and After Glycopyrrolate/Formoterol Fumarate Measured by Hyperpolarized 129Xe MRI in Chronic Obstructive Lung Disease/ E. Coleman, Z. Wang, M. He, E. Bier, J. Nouls, S. Womack, J. Mammarappallil, B. Driehuys, Y.C.T. Huang, Durham, NC, p.A1122 212 The Association Between Emphysema Detected by Lung Density Analysis and Healthcare Utilization in Patients Undergoing Lung Cancer Screening/ S. Vehar, P. Kirupaharan, R. Yadav, P.J. Mazzone, H. Choi, Cleveland, OH, p.A1123 213 Predictors of Pulmonary Function Test Acquisition in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation/ B. Bade, E. DeRycke, C. Ramsey, M. Skanderson, K.A. Crothers, S. Haskell, B. Bean-Mayberry, C. Brandt, L. Bastian, K.M. Akgun, New Haven, CT, p.A1124 214 Impact of Pulmonary Hypertension in Functional Status of Patients with Oxygen-Dependent Chronic Obstructive Pulmonary Disease/ G. Dahiya, M. Scoulos-Hanson, O. Ashraf, A. Kyvernitakis, M. Naddour, R.L. Benza, M. Kanwar, M.R. Balaan, Pittsburgh, PA, p.A1125 215 Impaired Mucus Hydration and Hydration Signaling Pathways in COPD/ C.R. Esther, W.K. O’Neal, W.H. Anderson, M. Kesimer, A.T. Hastie, R.G. Barr, R.P. Bowler, J.M. Wells, E. Oelsner, R.C. Boucher, Chapel Hill, NC, p.A1126 216 Cigarette Smoke Driven MUC5AC Increase and Airway Obstructions in COPD/ G. Radicioni, A. Ford, A. Ceppe, N.E. Alexis, W.K. O’Neal, R.C. Boucher, M. Kesimer, Chapel Hill, NC, p.A1127 217 Proteomic Profiling of Serum Exosomes to Identify Novel Biomarkers for COPD/ T. Koba, Y. Takeda, R. Narumi, T. Shiromizu, M. Kuroyama, Y. Futami, T. Takimoto, T. Matsuki, H. Kida, T. Tomonaga, A. Kumanogoh, Suita, Japan, p.A1128 218 Respiratory Syncytial Virus (RSV) Detection Is Associated with an Increased Inflammatory Response in Stable (non-Exacerbating) Chronic Obstructive Pulmonary Disease (COPD) Patients/ D.J. Wiseman, F. Kamal, L. Finney, A.I. Ritchie, J. Gent, M.R. Edwards, S.L. Johnston, G.C. Donaldson, P.J. Openshaw, J.A. Wedzicha, London, United Kingdom, p.A1129 219 Defining Repeatability Limits for Measuring Peak Inspiratory Flow Rates in Clinical Trials/ C. Barnes, D.A. Mahler, J.A. Ohar, G. Crater, South San Francisco, CA, p.A1130 220 A Meta-Analysis of Biomarkers in Asthma-COPD Overlap: A Call for Uniform Reporting/ F. Chau-Etchepare, M. Wilson, A.A. Zeki, Sacramento, CA, p.A1131 221 Suboptimal PIFR Associated with Greater Dyspnea in Chronic Obstructive Pulmonary Disease (COPD)/ D.A. Mahler, J.A. Ohar, J. Yun, E.J. Moran, C.N. Barnes, G.D. Crater, Hanover, NH, p.A1132 222 Analysis of Vaccination Effect Against Pneumococcal Infection with a Combined Course of Chronic Obstructive Pulmonary Disease and Chronic Heart Failure/ G. Ignatova, V. Antonov, Chelyabinsk, Russian Federation, p.A1133 223 Modulation of Macrophage Function in COPD by Phosphodiesterase-4 Inhibition/ C. Pu, S. Sethi, L.J. Grove, R.L. Kruzel, C. Berenson, Buffalo, NY, p.A1134 BASIC • CLINICAL • TRANSLATIONAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION A25 CRITICAL CARE: THE WIND IN THE WILLOWS - ARDS: OF SWINE AND MEN 9:15 a.m. - 11:15 a.m. OMNI DALLAS DOWNTOWN Dallas Ballroom E-F (Level 3) Abstract Summaries 9:15-9:45 Viewing/Discussion 9:45-11:15 Chairing: R.M. Baron, MD, Boston, MA J.A. Bastarache, MD, Nashville, TN R.S. Stephens, MD, Baltimore, MD 801 Nonpharmacological Interventions to Reduce Ventilator Dyssynchrony in Patients with the Acute Respiratory Distress Syndrome/ W.C. McGuire, M. Moss, D. Albers, P.D. Sottile, Aurora, CO, p.A1135 802 Impact of Ventilator-Subject Asynchrony on the Work of Breathing and Lung Damage in Experimental Acute Respiratory Distress Syndrome/ J.J.M. Wittenstein, M. Scharffenberg, R. Huhle, T. Bluth, M. Leidermann, G. Barana, A. De Ferrari, M. Herzog, A. Corona, S. Tauer, T. Koch, M. Gama de Abreu, Dresden, Germany, p.A1136 803 Phenotyping Entrainment Patterns During Mechanical Ventilation in ARDS Using the Campbell Diagram/ E. Baedorf Kassis, H. Su, S.H. Loring, D.S. Talmor, Boston, MA, p.A1137 804 Do Computed Tomography Scans Improve the Reliability of the Acute Respiratory Distress Syndrome (ARDS) Diagnosis?/ M. Wayne, J.I. McSparron, I. Co, M.W. Sjoding, Ann Arbor, MI, p.A1138 805 The Association Between Ventilatory Ratio and Mortality in PARDS/ J. Dong, C.J. Newth, A.K. Bhalla, Cambridge, MA, p.A1139 806 Respiratory System Mechanics and Mortality in Immunocompromised ARDS Patients/ A. Demoule, M. Antonelli, P. Pickkers, M. Soares, J. Rello, A. Perner, A. Van de Louw, P.R. Bauer, V. Lemiale, D. Grimaldi, I. Martin Loeches, T. Staudinger, S. Mehta, A. Kouatchet, N. Terzi, A. Barratt-Due, M. Valkonen, J. S. Nseir, G. Burghi, D. Mockart, M. Darmon, E. Azoulay, Paris, France, p.A1140 ATS 2019 • Dallas, TX 38 SUNDAY • MAY 19